Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,702 papers from all fields of science
Search
Sign In
Create Free Account
Aptin
Known as:
Aptin Duriles
, Aptin-Duriles
, AptinDuriles
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Alprenolol
Aptine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Hemodynamic effects of propranolol (Inderal) and H 56-28 (Aptin) in patients with acute myocardial infarction. A comparative study.
G. Lund-Larsen
,
E. Sivertssen
Acta Medica Scandinavica
2009
Corpus ID: 1213319
The hemodynamic effects of propranolol (Inderal®) and H 56/28 (Aptin®) were compared in a study of 17 patients in the acute stage…
Expand
2009
2009
Acute hemodynamic changes following beta-adrenergic blockade in hyperthyroidism.
I. Cullhed
,
A. Parrow
Acta Medica Scandinavica
2009
Corpus ID: 32580533
The acute hemodynamic effects of beta-receptor blockade in thyrotoxicosis have been studied in six cases. The blockade was…
Expand
2009
2009
A long-term study of the antihypertensive effect of alprenolol.
M. Comerford
,
A. Pringle
Acta medica Scandinavica. Supplementum
2009
Corpus ID: 36569780
Twenty patients, known to have essential hypertension, were treated for an average period of 30 months with alprenolol (Aptin…
Expand
2005
2005
Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate
Prof.Dr. M. Stauch
,
G. Grossmann
,
D. Wanjura
,
W. Adam
European Journal of Clinical Pharmacology
2005
Corpus ID: 21345291
SummaryThe effect of a controlled-release formulation of isosorbide-5-mononitrate (IS-5-MN) was studied in patients with coronary…
Expand
1991
1991
Fehlende Toleranz bei chronischer Anwendung von kontrolliert-freigesetztem Isosorbid-5-Mononitrat
Prof. Dr. M. Stauch
European Journal of Clinical Pharmacology
1991
Corpus ID: 9352565
ZusammenfassungAn Patienten mit koronarer Herzkrankheit (KHK) wurde die Wirkung einer kontrolliert freisetzenden Formulierung von…
Expand
1991
1991
Coleb-Duriles® bei Angina pectoris: Klinische Erfahrungen
G. Nyberg
European Journal of Clinical Pharmacology
1991
Corpus ID: 23930801
ZusammenfassungColeb-Duriles® enthält Isosorbid-5-Mononitrat (IS-5-MN) in einer kontrolliert-freisetzenden (Duriles…
Expand
1979
1979
Influence of pentobarbital on effect and plasma levels of alprenolol and 4‐hydroxy‐alprenolol
P. Collste
,
P. Seideman
,
K. Borg
,
K. Haglund
,
C. Bahr
Clinical pharmacology and therapy
1979
Corpus ID: 31152686
Six healthy subjects were given placebo and a single oral 0.2‐gm dose of alprenolol (Aptin) before and after 0.1 gin…
Expand
1978
1978
Contact eczema produced by a β‐adrenergic blocking agent (alprenolol)
L. Ekenvall
,
M. Forsbeck
1978
Corpus ID: 71421336
In a pharmaceutical industry, several cases of allergic contact eczema caused by the β‐adrenergic blocking agent alprenolol…
Expand
1970
1970
ALPRENOLOL (“APTIN”) IN ANGINA PECTORIS A DOUBLE–BUND MULTICENTRE TRIAL
J. Hickie
Medical Journal of Australia
1970
Corpus ID: 6879318
Alprenolol, a new beta–adrenergic blocking agent, has been used in 50 cases of severe angina pectoris, in a double–blind…
Expand
1968
1968
Inhibitory action of adrenergic blocking agents on reuptake and net uptake of noradrenaline in nerve granules.
U. V. von Euler
,
F. Lishajko
Acta Physiologica Scandinavica
1968
Corpus ID: 11578108
The effect of various adrenergic blocking agents on the reuptake and net uptake of noradrenaline (NA) in isolated adrenergic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE